Journal profile · Urology & Nephrology
PROGRES EN UROLOGIE
ISSN 1166-7087 · Elsevier Masson · FRANCE · Bimonthly
PROGRES EN UROLOGIE: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.19; hybrid open access; APC about USD 1,910; review 3–8 weeks (community reports); community-reported acceptance: easy (Elsevier website: 48%); 142 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
PROGRES EN UROLOGIE is published by Elsevier Masson and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Prostate Cancer Diagnosis and Treatment, Urinary Bladder and Prostate Research and Pelvic floor disorders treatments, together about 28.9% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Une publication rapide des travaux en urologie: retrouvez les derniers travaux de recherche, études et enquêtes, en Urologie, publiés sous la forme de revues, mises au point, articles originaux, notes techniques, cas cliniques pertinents et originaux, lettres à la rédaction, revues de la littérature, textes de recommandation,... La revue publie également des articles pour les infirmières en Urologie. Une approche pluridisciplinaire : Progrès en Urologie aborde toutes les pathologies urologiques. Aux 13 numéros de Progrès viennent s'ajouter 4 numéros de Progrès en Urologie Pelvi-Périnéologie
Source: LetPub
Research area (LetPub): Urology & Nephrology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Prostate Cancer Diagnosis and TreatmentMedicine11.3%
- Urinary Bladder and Prostate ResearchMedicine8.9%
- Pelvic floor disorders treatmentsMedicine8.6%
- Bladder and Urothelial Cancer TreatmentsMedicine6.6%
- Ureteral procedures and complicationsMedicine6.1%
- Prostate Cancer Treatment and ResearchMedicine5.4%
- Urological Disorders and TreatmentsMedicine5.4%
- Renal cell carcinoma treatmentMedicine4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.19LetPub ·
- CiteScore 2026-06
- 1.8LetPub ·
- SJR 2026-06
- 0.31LetPub ·
- SNIP 2026-06
- 0.52LetPub ·
- h-index
- 27LetPub ·
- h-index
- 42OpenAlex ·
- i10-index
- 632OpenAlex ·
- 2-year mean citedness
- 1.16OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 20.56%LetPub ·
Articles by year OpenAlex count · 6,415 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 109 | 40 | 13 |
| 2025 | 142 | 65 | 113 |
| 2024 | 173 | 112 | 367 |
| 2023 | 134 | 65 | 376 |
| 2022 | 151 | 79 | 677 |
| 2021 | 379 | 90 | 660 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- 48%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 1,910 / EUR 1,740 / GBP 1,530 / JPY 236,900 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier Masson
- Country or region
- FRANCE
- Language
- French
- Frequency
- Bimonthly
- ISSN
- 1166-7087
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about PROGRES EN UROLOGIE
What CAS zone is PROGRES EN UROLOGIE in?
In the 2025 upgraded edition of the CAS Journal Ranking, PROGRES EN UROLOGIE is in Zone 4 of Medicine, and in Zone 4 of the minor category Urology & Nephrology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of PROGRES EN UROLOGIE?
The latest impact factor listed by LetPub is 1.19; CiteScore 1.8, h-index 42.
How long does peer review take at PROGRES EN UROLOGIE?
Authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy (Elsevier website: 48%)”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index PROGRES EN UROLOGIE?
According to LetPub and DOAJ records, PROGRES EN UROLOGIE is indexed in SCIE and Scopus.
Is PROGRES EN UROLOGIE open access, and what is the APC?
PROGRES EN UROLOGIE is a hybrid journal. For open-access publication: APC about USD 1,910.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .